Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2005, Pages 118-122

  Ottmann, Oliver G ^a   Wassmann, Barbara ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; IMATINIB; PIPERAZINE DERIVATIVE; PREDNISONE; PYRIMIDINE DERIVATIVE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CHROMOSOME 22; CHROMOSOME 9; CLINICAL TRIAL (TOPIC); DRUG RESISTANCE; GENETICS; HUMAN; MINIMAL RESIDUAL DISEASE; MORTALITY; PHILADELPHIA 1 CHROMOSOME; PHYSIOLOGY; PROGNOSIS; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ADULT; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, NEOPLASM; FUSION PROTEINS, BCR-ABL; HUMANS; NEOPLASM, RESIDUAL; PHILADELPHIA CHROMOSOME; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; PROGNOSIS; PYRIMIDINES; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 33747403154     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2005.1.118     Document Type: Article

References (0)